Jefferies Reiterates MedAssets Rating

Jefferies & Company said today that it is reiterating its Hold rating on shares of MedAssets, Inc. MDAS. “We continue to believe that MDAS is well positioned in the healthcare market with a focus on cost-savings and revenue cycle,” Jefferies writes. “However, with moving parts such as Broadlane and caution on revenue cycle transformation deals, we believe that the stock is range bound until more clarity emerges.” MedAssets currently trades at $18.55.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst RatingsHealth CareHealth Care TechnologyJefferiesmedassets
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!